Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Bacteroidales - : Bacillus amyloliquefaciens group {B. Amyloliquefaciens} |
👪
The Effects of Dietary Bacillus amyloliquefaciens TL106 Supplementation, as an Alternative to Antibiotics, on Growth Performance, Intestinal Immunity, Epithelial Barrier Integrity, and Intestinal Microbiota in Broilers. Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 12 Issue 22 Pages: Pub: 2022 Nov 9 Epub: 2022 Nov 9 Authors Bao C , Zhang W , Wang J , Liu Y , Cao H , Li F , Liu S , Shang Z , Cao Y , Dong B , Html Article Publication |
| Increases Bacteroidales - : Bacillus amyloliquefaciens group {B. Amyloliquefaciens} |
👪
Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota. Journal of applied microbiology (J Appl Microbiol ) Vol: 131 Issue 1 Pages: 470-484 Pub: 2021 Jul Epub: 2020 Dec 18 Authors Bao CL , Liu SZ , Shang ZD , Liu YJ , Wang J , Zhang WX , Dong B , Cao YH , Publication |
| Decreases Bacteroidales - : Bacillus amyloliquefaciens group {B. Amyloliquefaciens} |
👪
Bacillus amyloliquefaciens SC06 alleviates the obesity of ob/ob mice and improves their intestinal microbiota and bile acid metabolism. Food & function (Food Funct ) Vol: 13 Issue 9 Pages: 5381-5395 Pub: 2022 May 10 Epub: 2022 May 10 Authors Zeng Z , Zhou Y , Xu Y , Wang S , Wang B , Zeng Z , Wang Q , Ye X , Jin L , Yue M , Tang L , Zou P , Zhao P , Li W , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
